de Bruyn, Magali
Sabino, João
Vandeputte, Doris
Vermeire, Séverine
Raes, Jeroen
Opdenakker, Ghislain
Article History
Received: 22 August 2017
Revised: 14 June 2018
Accepted: 18 June 2018
First Online: 3 September 2018
Competing interests
: S.V. reports grant support from AbbVie, MSD, and Takeda; speaker fees from AbbVie, MSD, Takeda, Ferring, Dr. Falk Pharma, Hospira, Pfizer Inc., and Tillots; and consultancy fees from AbbVie, MSD, Takeda, Ferring, Genentech/Roche, Shire, Pfizer Inc., Galapagos, Mundipharma, Hospira, Celgene, Second Genome, and Janssen Pharmaceuticals. J.R. reports consultancy fees from GSK Vaccines, Janssen Pharmaceuticals, Takeda. The remaining authors declare no competing interests.